These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 30676384)
1. Association between inflammatory biomarkers and neointimal response following elective implantation of the ABSORB bioresorbable vascular scaffold. Rampat R; Williams T; Mayo T; Mengozzi M; Ghezzi P; Hildick-Smith D; Cockburn J Coron Artery Dis; 2019 May; 30(3):183-187. PubMed ID: 30676384 [TBL] [Abstract][Full Text] [Related]
2. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data. Bourantas CV; Serruys PW; Nakatani S; Zhang YJ; Farooq V; Diletti R; Ligthart J; Sheehy A; van Geuns RJ; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Rapoza R; Veldhof S; Onuma Y; Garcia-Garcia HM EuroIntervention; 2015 Nov; 11(7):746-56. PubMed ID: 25308301 [TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography evaluation of the absorb bioresorbable scaffold performance for overlap versus non-overlap segments in patients with coronary chronic total occlusion: insight from the GHOST-CTO registry. Pereira GTR; La Manna A; Ichibori Y; Vergara-Martel A; Ramos Nascimento B; Samdani AJ; Capodanno D; D'Agosta G; Gravina G; Venuti G; Tamburino C; F Attizzani G Int J Cardiovasc Imaging; 2019 Oct; 35(10):1767-1776. PubMed ID: 31175527 [TBL] [Abstract][Full Text] [Related]
7. Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study. Toušek P; Kočka V; Malý M; Lisa L; Buděšínský T; Widimský P Heart Vessels; 2016 Jun; 31(6):841-5. PubMed ID: 25896128 [TBL] [Abstract][Full Text] [Related]
8. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial. Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961 [TBL] [Abstract][Full Text] [Related]
9. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process. Gutiérrez-Chico JL; Gijsen F; Regar E; Wentzel J; de Bruyne B; Thuesen L; Ormiston J; McClean DR; Windecker S; Chevalier B; Dudek D; Whitbourn R; Brugaletta S; Onuma Y; Serruys PW JACC Cardiovasc Interv; 2012 Apr; 5(4):428-35. PubMed ID: 22516401 [TBL] [Abstract][Full Text] [Related]
10. Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry. Latini RA; Granata F; Ielasi A; Varricchio A; Moscarella E; Tespili M; Cortese B Catheter Cardiovasc Interv; 2016 Sep; 88(3):380-7. PubMed ID: 27038332 [TBL] [Abstract][Full Text] [Related]
11. Long-Term Intracoronary Structural and Vasomotor Assessment of the ABSORB Bioresorbable Vascular Scaffold. Altisent OA; Goncalves-Ramírez LR; Fernández L; Viladés D; Gutiérrez E; Mitomo S; Latib A; Córdoba-Soriano JG; Adeliño R; Amat-Santos I; Muñoz JF; Elízaga J; Bezzera H; Pereira GTR; de Prado AP; Carrillo X; Fernández-Nofrerias E; Vilalta V; Rodríguez-Leor O; Llibre C; Fadeuilhe E; Trujillo A; Mauri J; de la Torre Hernández JM; Bayes-Genís A; Puri R Am J Cardiol; 2022 Apr; 168():55-63. PubMed ID: 35058053 [TBL] [Abstract][Full Text] [Related]
12. Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque? Brugaletta S; Radu MD; Garcia-Garcia HM; Heo JH; Farooq V; Girasis C; van Geuns RJ; Thuesen L; McClean D; Chevalier B; Windecker S; Koolen J; Rapoza R; Miquel-Hebert K; Ormiston J; Serruys PW Atherosclerosis; 2012 Mar; 221(1):106-12. PubMed ID: 22209268 [TBL] [Abstract][Full Text] [Related]
13. A randomized trial comparing two stent sizing strategies in coronary bifurcation treatment with bioresorbable vascular scaffolds - The Absorb Bifurcation Coronary (ABC) trial. Rampat R; Mayo T; Hildick-Smith D; Cockburn J Cardiovasc Revasc Med; 2019 Jan; 20(1):43-49. PubMed ID: 30170828 [TBL] [Abstract][Full Text] [Related]
14. Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery. Wu Y; Shen L; Ge L; Wang Q; Qian J; Zhang F; Yao K; Huang D; Chen Y; Ge J Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():630-7. PubMed ID: 26864162 [TBL] [Abstract][Full Text] [Related]
15. Re-endothelialisation after Synergy stent and Absorb bioresorbable vascular scaffold implantation in acute myocardial infarction: COVER-AMI study. Lhermusier T; Ohayon P; Boudou N; Bouisset F; Campelo-Parada F; Roncalli J; Elbaz M; Carrié D Trials; 2019 Apr; 20(1):210. PubMed ID: 30975219 [TBL] [Abstract][Full Text] [Related]
16. First in human evaluation of the vascular biocompatibility and biomechanical performance of a novel ultra high molecular weight amorphous PLLA bioresorbable scaffold in the absence of anti-proliferative drugs: Two-year imaging results in humans. Moncada M; Delgado JA; Colombo A; Gasior P; Ramzipoor K; Estrada A; Lee C; Dokko D; Granada JF Catheter Cardiovasc Interv; 2018 Sep; 92(3):E246-E253. PubMed ID: 29243353 [TBL] [Abstract][Full Text] [Related]
17. Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density. Nishino S; Sakuma M; Kanaya T; Nasuno T; Tokura M; Toyoda S; Abe S; Nakamura D; Tanaka K; Attizzani GF; Bezerra HG; Costa MA; Inoue T Int J Cardiovasc Imaging; 2019 Nov; 35(11):1971-1978. PubMed ID: 31218524 [TBL] [Abstract][Full Text] [Related]
18. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting. Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306 [No Abstract] [Full Text] [Related]
19. First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold. Kochman J; Kołtowski Ł; Tomaniak M; Jąkała J; Proniewska K; Legutko J; Roleder T; Piertrasik A; Rdzanek A; Kochman W; Brugaletta S; Opolski G; Regar E EuroIntervention; 2018 Apr; 13(18):e2201-e2209. PubMed ID: 29155384 [TBL] [Abstract][Full Text] [Related]
20. Direct bioresorbable vascular scaffold implantation: Feasibility and midterm results. Suárez de Lezo J; Martín P; Mazuelos F; Nóvoa J; Ojeda S; Pan M; Segura J; Hernández E; Romero M; Melián F; Medina A; Suárez de Lezo J Catheter Cardiovasc Interv; 2016 Apr; 87(5):E173-82. PubMed ID: 26268440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]